Professor Ed Wilson
Professor of Health Economics and Health Policy
E.C.F.Wilson@exeter.ac.uk
South Cloisters 3.09F
South Cloisters, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK
Overview
Ed is Professor of Health Economics and Health Policy, and director of the Peninsula Technology Assessment Group (PenTAG), one of 11 research units in the UK providing expert advice on the effects and costs of new drugs to the National Institute of Health and Care Excellence (NICE).
He trained in economics and then health economics at the University of York and holds a PhD in Health Economics from the University of East Anglia. He has worked at the Universities of York, Cambridge and East Anglia, as well as some time in industry and has expertise in decision analytic modelling and economic evaluation alongside clinical trials. Ed has applied these in a variety of disease areas including diabetes, stroke, dementia, Asperger’s syndrome, asthma, alcohol misuse, lupus, IVF, pregnancy and childbirth, erectile dysfunction, obesity, physical inactivity, essential thrombocythaemia, actinic keratosis, prostate cancer, renal cancer, melanoma, ulcerative colitis, cholecystitis, carpal tunnel syndrome and idiopathic pulmonary fibrosis.
His methodological research is in the area of efficient research design, specifically value of information analysis, a quantitative approach to setting research priorities making use of uncertainty in the results of economic evaluations to quantify the expected return on investment in further research.
Publications
Journal articles
Wilson E (In Press). Study Protocol: the Use of Rituximab in Nephrotic Glomerulonephritis. BMC Nephrology
Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson ECF, Heath A, et al (2024). Comment on: “Adding Value to CHEERS: New Reporting Standards for Value of Information Analyses”. Applied Health Economics and Health Policy, 22(2), 265-267.
Lee D, Burns D, Wilson E (2024). NICE's Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances. Pharmacoecon Open Author URL.
Kunst N, Siu A, Drummond M, Grimm S, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson ECF, Heath A, et al (2024). Reporting Economic Evaluations with Value of Information Analyses Using the CHEERS Value of Information (CHEERS-VOI) Reporting Guideline. MEDICAL DECISION MAKING, 44(2), 127-128. Author URL.
Kunst N, Siu A, Drummond M, Grimm SE, Grutters J, Husereau D, Koffijberg H, Rothery C, Wilson ECF, Heath A, et al (2023). Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration. Value Health, 26(10), 1461-1473. Abstract. Author URL.
Pham CT, Visvanathan R, Strong M, Wilson ECF, Lange K, Dollard J, Ranasinghe D, Hill K, Wilson A, Karnon J, et al (2023). Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals. Appl Health Econ Health Policy, 21(2), 315-325. Abstract. Author URL.
Esio-Bassey C, Wilson ECF, Hooper L, Rao N, Whitty JA (2023). Home Gardening of Yellow Cassava and Orange Maize for the Prevention of Nutritional Blindness in Children: an Economic Evaluation and Value of Information Analysis. Value in Health Regional Issues, 38, 77-84. Abstract.
Logan PA, Horne JC, Allen F, Armstrong SJ, Clark AB, Conroy S, Darby J, Fox C, Gladman JR, Godfrey M, et al (2022). A multidomain decision support tool to prevent falls in older people: the FinCH cluster RCT. Health Technol Assess, 26(9), 1-136. Abstract. Author URL.
Thornber K, Adshead F, Balayannis A, Brazier R, Brown R, Comber S, Court C, Davidson I, Depledge M, Farmer C, et al (2022). First, do no harm: time for a systems approach to address the problem of health-care-derived pharmaceutical pollution. The Lancet Planetary Health, 6(12), e935-e937.
Jackson CH, Baio G, Heath A, Strong M, Welton NJ, Wilson ECF (2022). Value of Information Analysis in Models to Inform Health Policy. Annual Review of Statistics and its Application, 9, 95-118. Abstract.
Rossi SH, Klatte T, Usher-Smith JA, Fife K, Welsh SJ, Dabestani S, Bex A, Nicol D, Nathan P, Stewart GD, et al (2021). A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound. Eur Urol Focus, 7(2), 407-419. Abstract. Author URL.
Corder KL, Brown HE, Croxson CHD, Jong ST, Sharp SJ, Vignoles A, Wilkinson PO, Wilson ECF, van Sluijs EMF (2021). A school-based, peer-led programme to increase physical activity among 13- to 14-year-old adolescents: the GoActive cluster RCT. Abstract.
Kassavou A, Houghton V, Edwards S, Brimicombe J, Wilson E, Griffin S, Sutton S (2021). Acceptability of the Medication Adherence for Patients Support intervention to improve adherence to patients prescribed medications for hypertension or comorbidities, as an adjunct to primary care: a qualitative study. J Health Psychol, 26(1), 168-180. Abstract. Author URL.
Thorn JC, Davies CF, Brookes ST, Noble SM, Dritsaki M, Gray E, Hughes DA, Mihaylova B, Petrou S, Ridyard C, et al (2021). Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey. Value Health, 24(4), 539-547. Abstract. Author URL.
Wilson ECF, Wreford A, Tamer P, Leonard K, Brechka H, Gnanapragasam VJ (2021). Economic Evaluation of Transperineal versus Transrectal Devices for Local Anaesthetic Prostate Biopsies. Pharmacoecon Open, 5(4), 737-753. Abstract. Author URL.
Yang M, Bishop A, Sussex J, Roland M, Jowett S, Wilson ECF (2021). Economic evaluation of patient direct access to NHS physiotherapy services. Physiotherapy, 111, 40-47. Abstract. Author URL.
Wilson ECF, Wastlund D, Moraitis AA, Smith GCS (2021). Late Pregnancy Ultrasound to Screen for and Manage Potential Birth Complications in Nulliparous Women: a Cost-Effectiveness and Value of Information Analysis. Value Health, 24(4), 513-521. Abstract. Author URL.
Wilson ECF (2021). Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models. Appl Health Econ Health Policy, 19(6), 789-795. Abstract. Author URL.
Logan PA, Horne JC, Gladman JRF, Gordon AL, Sach T, Clark A, Robinson K, Armstrong S, Stirling S, Leighton P, et al (2021). Multifactorial falls prevention programme compared with usual care in UK care homes for older people: multicentre cluster randomised controlled trial with economic evaluation. BMJ, 375 Abstract. Author URL.
Wilson ECF (2021). The Use of Economic Evaluation in Pediatric Research. J Pediatr, 233, 286-289. Author URL.
Foubister C, van Sluijs EMF, Vignoles A, Wilkinson P, Wilson ECF, Croxson CHD, Brown HE, Corder K (2021). The school policy, social, and physical environment and change in adolescent physical activity: an exploratory analysis using the LASSO. PLoS One, 16(4). Abstract. Author URL.
Smith GC, Moraitis AA, Wastlund D, Thornton JG, Papageorghiou A, Sanders J, Heazell AE, Robson SC, Sovio U, Brocklehurst P, et al (2021). Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis. Health Technol Assess, 25(15), 1-190. Abstract. Author URL.
Proctor J, Naughton F, Sloan M, Hopewell S, Brimicombe J, Prevost AT, Wilson ECF, Coleman T, Sutton S (2020). Assessment of the Effectiveness and Cost-Effectiveness of Tailored Web- and Text-Based Smoking Cessation Support in Primary Care (iQuit in Practice II): Protocol for a Randomized Controlled Trial. JMIR Res Protoc, 9(7). Abstract. Author URL.
Ahern AL, Woolston J, Wells E, Sharp SJ, Islam N, Lawlor ER, Duschinsky R, Hill AJ, Doble B, Wilson E, et al (2020). Clinical and cost-effectiveness of a diabetes education and behavioural weight management programme versus a diabetes education programme in adults with a recent diagnosis of type 2 diabetes: study protocol for the Glucose Lowering through Weight management (GLoW) randomised controlled trial. BMJ Open, 10(4). Abstract. Author URL.
Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H, et al (2020). Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods. Value Health, 23(6), 734-742. Abstract. Author URL.
Corder K, Sharp SJ, Jong ST, Foubister C, Brown HE, Wells EK, Armitage SM, Croxson CHD, Vignoles A, Wilkinson PO, et al (2020). Effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among UK adolescents: A cluster randomised controlled trial. PLoS Med, 17(7). Abstract. Author URL.
Hardeman W, Mitchell J, Pears S, Van Emmenis M, Theil F, Gc VS, Vasconcelos JC, Westgate K, Brage S, Suhrcke M, et al (2020). Evaluation of a very brief pedometer-based physical activity intervention delivered in NHS Health Checks in England: the VBI randomised controlled trial. PLoS Med, 17(3). Abstract. Author URL.
Jong ST, Croxson CHD, Foubister C, Brown HE, Guell C, Lawlor ER, Wells EK, Wilkinson PO, Wilson ECF, van Sluijs EMF, et al (2020). Reach, Recruitment, Dose, and Intervention Fidelity of the GoActive School-Based Physical Activity Intervention in the UK: a Mixed-Methods Process Evaluation. Children, 7(11), 231-231. Abstract.
Kim LG, Wilson ECF, Davison WJ, Clark AB, Myint PK, Potter JF (2020). Self-Monitoring and Management of Blood Pressure in Patients with Stroke or TIA: an Economic Evaluation of TEST-BP, a Randomised Controlled Trial. Pharmacoecon Open, 4(3), 511-517. Abstract. Author URL.
Newbould J, Ball S, Abel G, Barclay M, Brown T, Corbett J, Doble B, Elliott M, Exley J, Knack A, et al (2019). A ‘telephone first’ approach to demand management in English general practice: a multimethod evaluation. Health Services and Delivery Research, 7(17), 1-158. Abstract.
Charytonowicz D, Aubrey H, Bell C, Ferret M, Tsui K, Atfield R, Coleman N, Murray MJ, Wilson ECF (2019). Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients with Testicular Germ-Cell Tumors. Clin Genitourin Cancer, 17(4), e733-e744. Abstract. Author URL.
Rossi SH, Blick C, Nathan P, Nicol D, Stewart GD, Wilson ECF (2019). Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer. Value Health, 22(9), 981-987. Abstract. Author URL.
Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, et al (2019). Practical help for specifying the target difference in sample size calculations for RCTs: the DELTA2 five-stage study, including a workshop. Health Technol Assess, 23(60), 1-88. Abstract. Author URL.
Ayorinde JO, Summers DM, Pankhurst L, Laing E, Deary AJ, Hemming K, Wilson EC, Bardsley V, Neil DA, Pettigrew GJ, et al (2019). PreImplantation Trial of Histopathology in renal Allografts (PITHIA): a stepped-wedge cluster randomised controlled trial protocol. BMJ Open, 9(1). Abstract. Author URL.
Jerosch-Herold C, Shepstone L, Houghton J, Wilson ECF, Blake J (2019). Prognostic factors for response to treatment by corticosteroid injection or surgery in carpal tunnel syndrome (palms study): a prospective multicenter cohort study. Muscle Nerve, 60(1), 32-40. Abstract. Author URL.
Wastlund D, Moraitis AA, Dacey A, Sovio U, Wilson ECF, Smith GCS (2019). Screening for breech presentation using universal late-pregnancy ultrasonography: a prospective cohort study and cost effectiveness analysis. PLoS Med, 16(4). Abstract. Author URL.
Richards J, Hossain M, Summers D, Slater M, Bartlett M, Kosmoliaptsis V, Wilson EC, Lagaac R, Sidders A, Foley C, et al (2019). Surveillance arterioveNous fistulAs using ultRasound (SONAR) trial in haemodialysis patients: a study protocol for a multicentre observational study. BMJ Open, 9(7). Abstract. Author URL.
Wastlund D, Moraitis AA, Thornton JG, Sanders J, White IR, Brocklehurst P, Smith G, Wilson E (2019). The cost-effectiveness of universal late-pregnancy screening for macrosomia in nulliparous women: a decision analysis. BJOG, 126(10), 1243-1250. Abstract. Author URL.
Guagliano JM, Brown HE, Coombes E, Hughes C, Jones AP, Morton KL, Wilson ECF, van Sluijs EMF (2019). The development and feasibility of a randomised family-based physical activity promotion intervention: the Families Reporting Every Step to Health (FRESH) study. Pilot Feasibility Stud, 5 Abstract. Author URL.
Sampson CJ, Arnold R, Bryan S, Clarke P, Ekins S, Hatswell A, Hawkins N, Langham S, Marshall D, Sadatsafavi M, et al (2019). Transparency in Decision Modelling: What, Why, Who and How?. Pharmacoeconomics, 37(11), 1355-1369. Abstract. Author URL.
Wilson ECF, Usher-Smith JA, Emery J, Corrie P, Walter FM (2018). A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom. Value Health, 21(6), 658-668. Abstract. Author URL.
Gc VS, Suhrcke M, Hardeman W, Sutton S, Wilson ECF, Very Brief Interventions Programme Team (2018). Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care. Value Health, 21(1), 18-26. Abstract. Author URL.
Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, et al (2018). DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. BMJ, 363 Abstract. Author URL.
Cook JA, Julious SA, Sones W, Hampson LV, Hewitt C, Berlin JA, Ashby D, Emsley R, Fergusson DA, Walters SJ, et al (2018). DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial. Trials, 19(1). Abstract. Author URL.
Davison WJ, Myint PK, Clark AB, Kim LG, Wilson EC, Langley M, Potter JF (2018). Does self-monitoring and self-management of blood pressure after stroke or transient ischemic attack improve control? TEST-BP, a randomized controlled trial. Am Heart J, 203, 105-108. Abstract. Author URL.
Wilson ECF, Usher-Smith JA, Emery J, Corrie PG, Walter FM (2018). Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: an Application to Rates of Disease Progression in Undiagnosed and Untreated Melanoma. Value Health, 21(6), 669-676. Abstract. Author URL.
Laxy M, Wilson ECF, Boothby CE, Griffin SJ (2018). How good are GPs at adhering to a pragmatic trial protocol in primary care? Results from the ADDITION-Cambridge cluster-randomised pragmatic trial. BMJ Open, 8(6). Abstract. Author URL.
Martin A, Payne R, Wilson EC (2018). Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS. Appl Health Econ Health Policy, 16(3), 317-330. Abstract. Author URL.
Lakshman R, Sharp SJ, Whittle F, Schiff A, Hardeman W, Irvine L, Wilson E, Griffin SJ, Ong KK (2018). Randomised controlled trial of a theory-based behavioural intervention to reduce formula milk intake. Arch Dis Child, 103(11), 1054-1060. Abstract. Author URL.
Brown HE, Whittle F, Jong ST, Croxson C, Sharp SJ, Wilkinson P, Wilson EC, van Sluijs EM, Vignoles A, Corder K, et al (2017). A cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of the GoActive intervention to increase physical activity among adolescents aged 13-14 years. BMJ Open, 7(9). Abstract. Author URL.
Jerosch-Herold C, Houghton J, Blake J, Shaikh A, Wilson EC, Shepstone L (2017). Association of psychological distress, quality of life and costs with carpal tunnel syndrome severity: a cross-sectional analysis of the PALMS cohort. BMJ Open, 7(11). Abstract. Author URL.
Miani C, Martin A, Exley J, Doble B, Wilson E, Payne R, Avery A, Meads C, Kirtley A, Jones MM, et al (2017). Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technol Assess, 21(78), 1-128. Abstract. Author URL.
Doble B, Langdon PE, Shepstone L, Murphy GH, Fowler D, Heavens D, Malovic A, Russell A, Rose A, Mullineaux L, et al (2017). Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive-Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults with Asperger Syndrome. MDM Policy Pract, 2(2). Abstract. Author URL.
Newbould J, Abel G, Ball S, Corbett J, Elliott M, Exley J, Martin A, Saunders C, Wilson E, Winpenny E, et al (2017). Evaluation of telephone first approach to demand management in English general practice: observational study. BMJ, 358 Abstract. Author URL.
Laxy M, Wilson ECF, Boothby CE, Griffin SJ (2017). Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: an Update with Empirical Trial-Based Cost Data. Value Health, 20(10), 1288-1298. Abstract. Author URL.
Rossi SH, Hsu R, Blick C, Goh V, Nathan P, Nicol D, Fleming S, Sweeting M, Wilson ECF, Stewart GD, et al (2017). Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography. Br J Surg, 104(6), 648-659. Abstract. Author URL.
Wright C, Davey A, Elmore N, Carter M, Mounce L, Wilson E, Burt J, Roland M, Campbell J (2017). Patients' use and views of real-time feedback technology in general practice. Health Expect, 20(3), 419-433. Abstract. Author URL.
Coulton S, Stockdale K, Marchand C, Hendrie N, Billings J, Boniface S, Butler S, Deluca P, Drummond C, Newbury-Birch D, et al (2017). Pragmatic randomised controlled trial to evaluate the effectiveness and cost effectiveness of a multi-component intervention to reduce substance use and risk-taking behaviour in adolescents involved in the criminal justice system: a trial protocol (RISKIT-CJS). BMC Public Health, 17(1). Abstract. Author URL.
Doble B, Payne R, Harshfield A, Wilson ECF (2017). Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK. BMJ Open, 7(12). Abstract. Author URL.
Pears S, Bijker M, Morton K, Vasconcelos J, Parker RA, Westgate K, Brage S, Wilson E, Prevost AT, Kinmonth A-L, et al (2016). A randomised controlled trial of three very brief interventions for physical activity in primary care. BMC Public Health, 16(1). Abstract. Author URL.
Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbæk A, van den Donk M, Black JA, Tao L, Wilson EC, Davies MJ, et al (2016). A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Health Technol Assess, 20(64), 1-86. Abstract. Author URL.
GC V, Wilson ECF, Suhrcke M, Hardeman W, Sutton S, VBI Programme Team (2016). Are brief interventions to increase physical activity cost-effective? a systematic review. Br J Sports Med, 50(7), 408-417. Abstract. Author URL.
Mitchell J, Hardeman W, Pears S, Vasconcelos JC, Prevost AT, Wilson E, Sutton S, VBI Research Team (2016). Effectiveness and cost-effectiveness of a very brief physical activity intervention delivered in NHS Health Checks (VBI Trial): study protocol for a randomised controlled trial. Trials, 17(1). Abstract. Author URL.
Wilson ECF, Mugford M, Barton G, Shepstone L (2016). Efficient Research Design: Using Value-of-Information Analysis to Estimate the Optimal Mix of Top-down and Bottom-up Costing Approaches in an Economic Evaluation alongside a Clinical Trial. Med Decis Making, 36(3), 335-348. Abstract. Author URL.
Burns DK, Wilson ECF, Browne P, Olive S, Clark A, Galey P, Dix E, Woodhouse H, Robinson S, Wilson A, et al (2016). The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: an Economic Evaluation Alongside a Randomised Controlled Trial. Appl Health Econ Health Policy, 14(1), 105-115. Abstract. Author URL.
Wilson ECF, Stanley G, Mirza Z (2016). The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department. Appl Health Econ Health Policy, 14(2), 205-215. Abstract. Author URL.
Langdon PE, Murphy GH, Shepstone L, Wilson ECF, Fowler D, Heavens D, Malovic A, Russell A, Rose A, Mullineaux L, et al (2016). The People with Asperger syndrome and anxiety disorders (PAsSA) trial: a pilot multicentre, single-blind randomised trial of group cognitive-behavioural therapy. BJPsych Open, 2(2), 179-186. Abstract. Author URL.
Garner P, Hopewell S, Chandler J, MacLehose H, Schünemann HJ, Akl EA, Beyene J, Chang S, Churchill R, Dearness K, et al (2016). When and how to update systematic reviews: consensus and checklist. BMJ, 354 Abstract. Author URL.
Wilson ECF (2015). A practical guide to value of information analysis. Pharmacoeconomics, 33(2), 105-121. Abstract. Author URL.
Tao L, Wilson ECF, Wareham NJ, Sandbaek A, Rutten GEHM, Lauritzen T, Khunti K, Davies MJ, Borch-Johnsen K, Griffin SJ, et al (2015). Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial. Diabet Med, 32(7), 907-919. Abstract. Author URL.
Lakshman R, Whittle F, Hardeman W, Suhrcke M, Wilson E, Griffin S, Ong KK (2015). Effectiveness of a behavioural intervention to prevent excessive weight gain during infancy (The Baby Milk Trial): study protocol for a randomised controlled trial. Trials, 16 Abstract. Author URL.
Wilson AM, Browne P, Olive S, Clark A, Galey P, Dix E, Woodhouse H, Robinson S, Wilson ECF, Staunton L, et al (2015). The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial. BMJ Open, 5(3). Abstract. Author URL.
Jerosch-Herold C, Shepstone L, Wilson ECF, Dyer T, Blake J (2014). Clinical course, costs and predictive factors for response to treatment in carpal tunnel syndrome: the PALMS study protocol. BMC Musculoskelet Disord, 15 Abstract. Author URL.
Wilson E (2014). Research: increasing value, reducing waste. Lancet, 383(9923), 1123-1124. Author URL.
Wilson ECF, Shulgina L, Cahn AP, Chilvers ER, Parfrey H, Clark AB, Twentyman OP, Wilson AM (2014). Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial. Pharmacoeconomics, 32(1), 87-99. Abstract. Author URL.
Langdon PE, Murphy GH, Wilson E, Shepstone L, Fowler D, Heavens D, Malovic A, Russell A (2013). Asperger syndrome and anxiety disorders (PAsSA) treatment trial: a study protocol of a pilot, multicentre, single-blind, randomised crossover trial of group cognitive behavioural therapy. BMJ Open, 3(7). Abstract. Author URL.
Shulgina L, Cahn AP, Chilvers ER, Parfrey H, Clark AB, Wilson ECF, Twentyman OP, Davison AG, Curtin JJ, Crawford MB, et al (2013). Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosis. Thorax, 68(9), 884-885. Author URL.
Rutter CL, Jones C, Dhatariya KK, James J, Irvine L, Wilson ECF, Singh H, Walden E, Holland R, Harvey I, et al (2013). Determining in-patient diabetes treatment satisfaction in the UK--the DIPSat study. Diabet Med, 30(6), 731-738. Abstract. Author URL.
Gurusamy KS, Wilson E, Koretz RL, Allen VB, Davidson BR, Burroughs AK, Gluud C (2013). Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?. PLoS One, 8(12). Abstract. Author URL.
Tao L, Wilson ECF, Griffin SJ, Simmons RK, ADDITION-Europe study team (2013). Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort. Value Health, 16(6), 1074-1080. Abstract. Author URL.
Emery JD, Wilson ECF, Kinmonth AL, Prevost AT, Morris HC, Humphrys E, Hall PN, Burrows N, Bradshaw L, Walls J, et al (2013). The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model. Value Health, 16(2), 356-366. Abstract. Author URL.
Shulgina L, Cahn AP, Chilvers ER, Parfrey H, Clark AB, Wilson ECF, Twentyman OP, Davison AG, Curtin JJ, Crawford MB, et al (2013). Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax, 68(2), 155-162. Abstract. Author URL.
Walter FM, Morris HC, Humphrys E, Hall PN, Prevost AT, Burrows N, Bradshaw L, Wilson ECF, Norris P, Walls J, et al (2012). Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ, 345 Abstract. Author URL.
Gurusamy K, Wilson E, Burroughs AK, Davidson BR (2012). Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones: cost-utility and value-of-information analysis. Appl Health Econ Health Policy, 10(1), 15-29. Abstract. Author URL.
Price D, Musgrave S, Wilson E, Sims E, Shepstone L, Blyth A, Murdoch J, Mugford M, Juniper E, Ayres J, et al (2011). A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Health Technol Assess, 15(21), 1-132. Author URL.
Wilson E (2011). Economic evaluations based on decision models: a response to Muston et al. J Dermatolog Treat, 22(5), 298-301. Author URL.
Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RFT, Juniper EF, Ayres JG, Kemp L, Blyth A, et al (2011). Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med, 364(18), 1695-1707. Abstract. Author URL.
Wilson E, Gurusamy K, Gluud C, Davidson BR (2010). Authors' reply: Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis (BrJ Surg 2010; 97: 210-219). British Journal of Surgery, 97(7).
Wilson EC, Ford GA, Robinson T, Mistri A, Jagger C, Potter JF (2010). Controlling hypertension immediately post stroke: a cost utility analysis of a pilot randomised controlled trial. Cost Eff Resour Alloc, 8 Abstract. Author URL.
Wilson ECF (2010). Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model. Pharmacoeconomics, 28(11), 1055-1064. Abstract. Author URL.
Wilson ECF, Sims EJ, Musgrave SD, Shepstone L, Blyth A, Murdoch J, Mugford HM, Juniper EF, Ayres JG, Wolfe S, et al (2010). Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. Pharmacoeconomics, 28(7), 585-595. Abstract. Author URL.
Wilson ECF, Price D, Musgrave SD, Sims EJ, Shepstone L, Murdoch J, Mugford HM, Blyth A, Juniper EF, Ayres JG, et al (2010). Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. Pharmacoeconomics, 28(7), 597-608. Abstract. Author URL.
Wilson E, Gurusamy K, Gluud C, Davidson BR (2010). Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg, 97(2), 210-219. Abstract. Author URL.
Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR (2010). Erratum: Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis (British Journal of Surgery (2010) 97 (141-150)). British Journal of Surgery, 97(4).
Gurusamy K, Samraj K, Gluud C, Wilson E, Davidson BR (2010). Meta-analysis of randomized controlled trials on the safety and effectiveness of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg, 97(2), 141-150. Abstract. Author URL.
Walter FM, Morris HC, Humphrys E, Hall PN, Kinmonth AL, Prevost AT, Wilson EC, Burrows N, Norris P, Johnson M, et al (2010). Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Fam Pract, 11 Abstract. Author URL.
Wilson E, Thalanany M, Shepstone L, Charlesworth G, Poland F, Harvey I, Price D, Reynolds S, Mugford M (2009). Befriending carers of people with dementia: a cost utility analysis. Int J Geriatr Psychiatry, 24(6), 610-623. Abstract. Author URL.
Potter J, Mistri A, Brodie F, Chernova J, Wilson E, Jagger C, James M, Ford G, Robinson T (2009). Controlling Hypertension and X Hypotension Immediately Post Stroke (CHHIPS) - a randomised controlled trial. HEALTH TECHNOLOGY ASSESSMENT, 13(9), 1-+. Author URL.
Potter J, Mistri A, Brodie F, Chernova J, Wilson E, Jagger C, James M, Ford G, Robinson T (2009). Controlling hypertension and hypotension immediately post stroke (CHHIPS)--a randomised controlled trial. Health Technol Assess, 13(9), iii-73. Abstract. Author URL.
Wilson ECF, Peacock SJ, Ruta D (2009). Priority setting in practice: what is the best way to compare costs and benefits?. Health Econ, 18(4), 467-478. Abstract. Author URL.
Wilson ECF, Wilson JV (2009). Time to review short courses of antibiotics. Pharmaceutical Journal, 282(7552), 590-594. Abstract.
Charlesworth G, Shepstone L, Wilson E, Reynolds S, Mugford M, Price D, Harvey I, Poland F (2008). Befriending carers of people with dementia: randomised controlled trial. BMJ, 336(7656), 1295-1297. Abstract. Author URL.
Charlesworth G, Shepstone L, Wilson E, Thalanany M, Mugford M, Poland F (2008). Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? a randomised controlled trial. Health Technol Assess, 12(4), iii-78. Abstract. Author URL.
Wilson E (2007). A matter of perspective [2]. Pharmaceutical Journal, 278(7434).
Cuthbertson BH, Rattray J, Johnston M, Wildsmith JA, Wilson E, Hernendez R, Ramsey C, Hull AM, Norrie J, Campbell M, et al (2007). A pragmatic randomised, controlled trial of intensive care follow up programmes in improving longer-term outcomes from critical illness. The PRACTICAL study. BMC Health Serv Res, 7 Abstract. Author URL.
Pacini M, Smith RD, Wilson ECF, Holland R (2007). Home-based medication review in older people - is it cost effective?. PHARMACOECONOMICS, 25(2), 171-180. Author URL.
Wilson E, Sussex J, Macleod C, Fordham R (2007). Prioritizing health technologies in a Primary Care Trust. J Health Serv Res Policy, 12(2), 80-85. Abstract. Author URL.
Wilson ECF, Jayne DRW, Dellow E, Fordham RJ (2007). The cost-effectiveness of mycophenolate mofetil as firstline therapy in active lupus nephritis. Rheumatology, 46(7), 1096-1101. Abstract.
Wilson ECF, Rees J, Fordham RJ (2006). Developing a prioritisation framework in an English Primary Care Trust. Cost Effectiveness and Resource Allocation, 4 Abstract.
Ledger WL, Anumba D, Marlow N, Thomas CM, Wilson ECF (2006). The costs to the NHS of multiple births after IVF treatment in the UK. BJOG: an International Journal of Obstetrics and Gynaecology, 113(1), 21-25. Abstract.
Heller RF, Gemmell I, Wilson ECF, Fordham R, Smith RD (2006). Using economic analyses for local priority setting: the population cost-impact approach. Applied Health Economics and Health Policy, 5(1), 45-54. Abstract.
Wilson ECF (2005). Trastuzumab for early breast cancer raises important issues [2]. British Medical Journal, 331(7523).
Scuffham P, Chalmers D, O'Hare D, Wilson E (2002). Direct and indirect cost of general aviation crashes. Aviat Space Environ Med, 73(9), 851-858. Abstract. Author URL.
Wilson ECF, McKeen ES, Scuffham PA, Brown MCJ, Wylie K, Hackett G (2002). The cost to the United Kingdom National Health Service of managing erectile dysfunction: the impact of sildenafil and prescribing restrictions. PharmacoEconomics, 20(13), 879-889. Abstract.
Chapters
Shemilt I, Aluko P, Graybill E, Craig D, Henderson C, Drummond M, Wilson ECF, Robalino S, Vale L (2019). Economic evidence. In (Ed) Cochrane Handbook for Systematic Reviews of Interventions, 507-523. Abstract.
Shemilt I, Wilson E, Vale L (2014). Quality Assessment in Modeling in Decision Analytic Models for Economic Evaluation. In (Ed) Encyclopedia of Health Economics, 218-223. Abstract.
Wilson E, Abrams K (2010). From Evidence-Based Economics to Economics-Based Evidence: Using Systematic Review to Inform the Design of Future Research. In (Ed) Evidence-Based Decisions and Economics: Health Care, Social Welfare, Education and Criminal Justice, Second Edition, 146-161.
Lister G, Fordham R, Mugford M, Olukoga A, Wilson E, McVey D (2008). Evaluating the societal costs of potentially preventable illnesses: Developing a common approach. In (Ed) Future Public Health: Burdens, Challenges and Opportunities, 233-247.
Conferences
Corder K, Sharp SJ, Foubister C, Brown HE, Jong ST, Wells EK, Armitage S, Croxson CHD, Wilkinson PO, Wilson ECF, et al (2019). Effectiveness of the GoActive intervention to increase physical activity in adolescents aged 13-14 years: a cluster randomised controlled trial. Author URL.
Mason D, Lamming L, Wilson E, Gc VS, Pears S, Morton K, Bijker M, Sutton S, Hardeman W (2012). The effectiveness and cost-effectiveness of pedometers to increase physical activity: a systematic review and meta-analysis. Author URL.
Wilson EC, Jayne DR, Dellow E, Fordham RJ (2007). The cost-effectiveness of mycophenolate mofetil (MMF) as first-line therapy in active lupus nephritis. Author URL.
Bagust A, Wilson E, Downs KE, Perry AS, Harrison DJ (2002). Utility and quality of life in the CODE-2 study for type 2 diabetes. Author URL.
External Engagement and Impact
Awards
- Finalist, Wolfson Economics Prize 2021 (“The Smart ED” in response to “How would you design and plan new hospitals to radically improve patient experiences, clinical outcomes, staff wellbeing, and integration with wider health and social care?”)
Committee/panel activities
- Member, NICE Highly Specialised Technologies Appraisal Committee
- Member, NIHR HTA Clinical Evaluation and Trials Funding Committee
